Article citationsMore >>

Howard, S. C., Jones, D. P., & Pui, C. H. (2011). The tumor lysis syndrome. The New England journal of medicine, 364(19), 1844-1854.

has been cited by the following article:

Article

Spontaneous Tumor Lysis Syndrome in Myeloproliferative Disorder: A Rarely Reported Clinical Entity

1Department of Internal Medicine, Conemaugh Health System, Johnstown PA 15905, USA


American Journal of Medical Case Reports. 2020, Vol. 8 No. 10, 361-362
DOI: 10.12691/ajmcr-8-10-10
Copyright © 2020 Science and Education Publishing

Cite this paper:
Sadaquat Liaqat, Asghar Marwat, Munawwar Hussain. Spontaneous Tumor Lysis Syndrome in Myeloproliferative Disorder: A Rarely Reported Clinical Entity. American Journal of Medical Case Reports. 2020; 8(10):361-362. doi: 10.12691/ajmcr-8-10-10.

Correspondence to: Munawwar  Hussain, Department of Internal Medicine, Conemaugh Health System, Johnstown PA 15905, USA. Email: mhussain@conemaugh.org

Abstract

Tumor lysis syndrome (TLS) is an oncologic emergency resulting from a massive breakdown of tumor cells. It causes electrolyte imbalance and acute renal failure. It occurs after the initiation of chemotherapy. Spontaneous tumor lysis syndrome is seen in Burkitt's lymphoma, acute lymphoid leukemia, diffuse large B-cell lymphoma, and solid tumors like breast and prostate cancer. Spontaneous tumor lysis syndrome is exceedingly rare in patients with myeloproliferative disorders. We report a rare case of spontaneous tumor lysis in an 82-year-old female patient with a myeloproliferative disorder.

Keywords